Skip to main contentSkip to navigation
Sirius Investors

SVNS.L Stock: Solvonis Therapeutics plc Stock Price, Analysis & Insights

Get live SVNS.L stock price $0.21, comprehensive Solvonis Therapeutics plc stock analysis, charts, news, and expert forecast. Real-time SVNS.L stock data and investment insights.

0.21
3.00%Today
SVNS.LSolvonis Therapeutics plc • London Stock Exchange • Industrials
Market Cap
14.02M
Volume
5.38M
52W High
0.40
52W Low
0.17

Loading chart data...

Investment Score

Annual (latest period)
Unavailable

A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.

Score unavailable for this asset.

0-39

Defensive posture

40-54

Mixed / wait for confirmation

55-69

Constructive setup

70-100

Attractive zone

Total Score

Value

Cheapness vs fundamentals and cash generation

Quality

Durability of profitability and balance sheet

Momentum

Price trend strength and persistence

Professional usage: treat the score as a ranking and risk-filtering tool, then confirm with earnings revision trend, competitive positioning, and valuation relative to peers before capital allocation.

Company Overview

Graft Polymer (UK) Plc, set to become Solvonis Therapeutics plc in January 2025, is dedicated to the research and development of advanced polymer modification technologies and techniques. Its operations span the United Kingdom, Slovenia, and across E...

Company Information

CEO
Anthony James Tennyson
Sector
Industrials
Industry
Industrial - Machinery
Employees
3

Contact Information

Address
Eccleston Yards
Country
GB

Investment Analysis & Business Insights

Industrials
Industrial - Machinery

Investment Highlights

Strong presence in the Industrials sector with established market position

Important Investment Considerations

  • All investments carry risk, including potential loss of principal for Solvonis Therapeutics plc shareholders
  • Market volatility can significantly impact stock price, especially for smaller companies
  • Sector-specific risks in Industrials may affect company performance
  • Past performance does not guarantee future results for Solvonis Therapeutics plc
  • Investors should consider how Solvonis Therapeutics plc fits within their overall portfolio allocation

Market Cap

14.02M

Beta

1.19

Data Sources & Methodology

Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.

About Industrials Sector

The Industrials sector includes companies that manufacture machinery, provide transportation services, and offer industrial products and services.

Industrials (1D)

80/100 ⭐⭐⭐⭐⭐

Overall
+3.1%
NYSE
+2.6%
NASDAQ
+3.6%
Sector1D1W1MP/EScore
Industrials+3.1%+2.4%+6.2%43.1
80/100⭐⭐⭐⭐⭐
Technology+3.3%+3.6%+5.6%51.3
77/100⭐⭐⭐⭐⭐
Financial Services+0.4%+1.4%+2.0%19.6
69/100⭐⭐⭐⭐
Basic Materials+1.8%+1.2%+2.9%27.4
68/100⭐⭐⭐⭐
Healthcare+1.3%+0.3%+3.9%30.6
67/100⭐⭐⭐⭐
Consumer Cyclical+1.8%+2.4%+1.9%54.8
51/100⭐⭐⭐
Communication Services+0.1%-0.4%+1.2%22.0
47/100⭐⭐⭐
Consumer Defensive-0.7%+0.2%-3.8%31.0
25/100⭐⭐
Real Estate-0.2%-1.9%-0.8%49.5
25/100⭐⭐
Utilities+0.9%-2.4%-6.2%25.8
22/100
Energy-1.6%-5.6%-2.1%35.9
18/100

Sector returns combine NYSE and NASDAQ averages. P/E is the latest blended sector multiple. Sector score ranks each sector vs peers using percentile ranks (not fixed thresholds): 48% 1M + 24% 1W + 8% 1D + 20% P/E (lower P/E ranks higher). Data as of 2026-06-12.